Mangaluru: Husband, wife die as truck knocks down scooter at Nanthoor

Bengaluru, Apr 28: Ayurveda company, TotalAyurvedaCare.com recently launched a novel telemedicine platform that blends traditional Ayurvedic practices with modern technology, giving patients face-to-face interactions with Ayurvedic doctors.

Through the website, patients can book an appointment with a doctor and receive a consultation. Following this consultation, the doctor will prescribe Ayurvedic medicines and provide nutritional advice.

"COVID-19 has brought many unexpected changes to our lives, especially in the healthcare sectors where patients are now asked not to visit hospitals or doctors clinics unless it is a dire emergency. While social distancing and hand washing are some of the keys to containing the spread of the virus, we realized that boosting one's immunity plays a very vital role in keeping healthy. Our Telemedicine portal is ideal as patients can have access to Ayurvedic doctors at the comfort of their homes while minimizing risk to both patient and doctor", said Ed Lateef, Founder and CEO of TotalAyurvedaCare.com.

"The holistic care and treatment is completely personalized for every individual. With highly qualified and experienced doctors, we are on a mission to make the global community a healthy and happy place with Ayurveda. The online platform of TotalAyurvedaCare.com is for everyone to transform their lives. Ayurveda is the science of life and longevity and teaches us about the power of nature, its cycles, and its elements. We understand that Ayurveda is aimed at not only treating the condition but also helps to maintain the balance of soul and mind", he added.

TotalAyurvedaCare's objective is to increase accessibility of Ayurvedic treatments, with the streamlined website allowing patients to register for online consultation easily.

During the registration process, the patient will have to select their condition, doctor of choice and schedule the appointment. Payments occur online through a secured payment gateway.

Currently, the platform supports payment methods including netbanking, debit card, credit card, and PayTM. The platform also allows patients to review their doctors.

TotalAyurvedaCare.com is a division of Total Herbal Care, a company with strategic interests in herbal brands. Founded by Ed Lateef in 2001, for the retail and distribution of Ayurvedic products in the US, it also began operations in Europe in 2003 and then was merged with The Himalaya Drug Company LTD Europe (SIA The Himalaya Drug Company), which was co-founded by Ed Lateef.

As a part of their launch, TotalAyurvedaCare.com is offering free appointments of 30 minutes each for the first 200 participants. The online Ayurvedic Doctor consultation from Total Ayurveda Care is suitable for all the age groups including children.

The highly qualified and experienced Ayurvedic physicians offer personalized consultation for multiple health issues like diabetes, obesity, skin conditions, hair issues, hypertension, stress, anxiety, gastrointestinal problems, etc.

Total Ayurveda Care also offers specialized nutritional consulting, which is based on your current state of health, dietary habits and health issues.

Mar 5: The government on Thursday asserted that there is no shortage of raw ingredients or medicines in the country as it has taken various initiatives to tackle the challenge posed by the coronavirus outbreak.

All initiatives are also being taken to ensure that there is no impact of the disease in India, Minister of Chemicals and Fertilizers D V Sadananda Gowda said.

"There is no shortage of any APIs in the country. We have sufficient APIs (active pharmaceutical ingredients) and medicines in the country," he said.

Gowda was addressing the 5th international exhibition and conference on the pharmaceutical and medical industry organised by the Department of Pharmaceuticals, Gujarat government and industry chamber Ficci here.

For another three months there is no shortage for undertaking production in the pharma sector, he added.

"Our government has taken all initiatives to ensure that as far as our country is concerned the coronavirus should be stopped, and there is no hazard as far as this issue is concerned," Gowda reiterated.

Coronavirus is a challenge and "we should make all efforts that need to be taken..., " he added.

On Tuesday, India, the world's largest maker of generic drugs, restricted the export of common medicines such as paracetamol and 25 other pharmaceutical ingredients and drugs made from them, as it looks to prevent shortages amid concerns of the coronavirus outbreak turning into a pandemic.

Besides over-the-counter painkiller and fever reducer paracetamol, drugs restricted for exports included common antibiotics metronidazole, and those used to treat bacterial and other infections as well as Vitamin B1 and B12 ingredients.

A notification by the Directorate General of Foreign Trade (DGFT) had said the export of 26 active pharmaceutical ingredients (APIs) and formulations would require licence.

Global oil markets remained under intense pressure on Tuesday, with Brent crude dropping below $20 per barrel for the first time in 18 years while other major benchmarks across the world tumbled. 

Brent, the international crude marker, slipped to $18.10, indicating that markets see no immediate let-up to the collapse in oil demand that sent some US oil benchmarks plunging under $0 for the first time on Monday, leaving producers paying for buyers to take their oil away while available storage is scarce.

Coronavirus has sent the oil sector into a state of crisis, with lockdowns implemented by authorities to smother the outbreak slashing demand for crude by as much as a third.

Contracts for the US benchmark West Texas Intermediate for delivery next month tumbled as low as minus $40 a barrel on Monday. Analysts at Citi warned that “if global storage worsens more quickly, Brent could chase WTI down to the bottom”.

The collapse in the May WTI contract was partly a technical product of the fact that it expires on Tuesday, meaning trading volumes were low and making the contract for June delivery more noteworthy, analysts said. That contract held above $20 a barrel on Monday but slid as much as 42 per cent on Tuesday to trade at lows of $11.79, suggesting the blowout in the May contract was more than a blip and that the entire global oil market faced challenges.

Goldman Sachs analysts said the June contact was likely to face downward pressure in the coming weeks, pointing to the “still unresolved market surplus”.

“As storage becomes saturated, price volatility will remain exceptionally high in coming weeks,” they said. “But with ultimately a finite amount of storage left to fill, production will soon need to fall sizeably to bring the market into balance, finally setting the stage for higher prices once demand gradually recovers.”

Warren Patterson, head of commodities strategy at ING, said it was likely that “storage this time next month will be even more of an issue, given the surplus environment”.

“And so in the absence of a meaningful demand recovery, negative prices could return for June,” he added.

European equities traded lower, partly dragged down by weaker energy stocks. The continent-wide Stoxx 600 was down 1.9 per cent, with its oil and gas sub-index dropping 3.3 per cent. In London the FTSE shed 1.7 per cent, while Frankfurt’s Dax slid 2.3 per cent. 

Equities were also broadly lower in Asia, with futures tipping US stocks to fall 1 per cent when trading in New York begins later.

On Wall Street overnight, the S&P 500 closed down 1.8 per cent, partly because of weakness in energy shares, but also due to increased pessimism over the time it will take for countries to emerge from lockdowns.

In fixed income, the yield on the 10-year US Treasury fell 0.03 percentage points to 0.585 per cent as investors retreated to the safety of the debt.